Fair Value Distribution — percentile bands
19.6% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
6.5%/yr
±7.3% · revenue growth to justify current price
FCF-Based Reverse DCF
1.2%/yr
±2.9% · FCF growth to justify current price
THE GAP
Market pricing margin expansion or capex normalization
KEY VALUE DRIVERS
Spearman correlation — what moves this valuation most
Corteva, Inc.
No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.
No analysis yet
No analysis yet
CTVA 2025 10-K: Planned separation into Seed and Crop Protection. Seed strong with dominant Enlist E3; Crop Protection faces margin pressure from patents/generics. Regulatory (EPA), geopolitical (Chin...